Immunologic Analysis of Peripheral Blood and Aspirated Thromb In AMI Patients

Immunologic Analysis of Aspired Thromb and Circulatory Immune Cell in AMI Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02704806

Acronym

ATAIA

Enrollment

Registered

2016-03-10

Start date

2016-04-30

Completion date

2018-04-30

Last updated

2016-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immunol Feature in Circulation and Thromb in AMI Patients

Brief summary

Researchers use FCM to analyze the immunol cell feature and its corresponding activation status, as well as the thromb aspirated through the thromb aspiration device in AMI patients

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

30 Years to 80 Years

Healthy volunteers

Inclusion criteria

* uncomplicated AMI patients

Exclusion criteria

* any self immune disease and recent (within 1 month) or any chronic infection

Design outcomes

Primary

Measure	Time frame
immunologic feature of AMI patients	1 month

Outcome results